ChiCTR2000040146: A Phase II, Randomized, Double-blinded, Placebo-controlled, Dose-finding Clinical Study to Evaluate the Safety and Immunogenicity of Different Doses of INO-4800 Intradermal Injection Followed by Electroporation in Healthy Adult and Elderly Volunteers |
|
|
| Completed | 2 | 640 | | pGX9501 1.0 mg / placebo ;pGX9501 1.0 mg / placebo ;pGX9501 2.0 mg/ placebo ;pGX9501 2.0 mg/ placebo | Jiangsu Provincial Center for Disease Control and Prevention; Advaccine (Suzhou) Biopharmaceutical, Ltd., Sponosor | Novel Coronavirus Pneumonia (COVID-19) | | | | |
ChiCTR2000038152: A Single-center, Randomized, Double-blind, Placebo-controlled, Dose Ranging Phase I Study to Evaluate the Safety, Tolerability, and Immunogenicity of INO-4800, Administered Intradermally Followed by Electroporation in Healthy Volunteers |
|
|
| Completed | 1 | 45 | | Vaccine INO-4800 ;placebo | Huashan Hospital Affiliated to Fudan University; Huashan Hospital Affiliated to Fudan University, Sponosor Investment | Novel Coronavirus Pneumonia (COVID-19) | | | | |
NCT06420349: NXP800 for the Treatment of Patients with Advanced or Metastatic Cholangiocarcinoma |
|
|
| Recruiting | 1 | 30 | US | Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, Computerized Tomography (CT) scan, CT, CT Scan, tomography, Heat Shock Factor 1 Pathway Inhibitor NXP800, CCT 361814, CCT-361814, CCT361814, HSF1 Pathway Inhibitor NXP800, NXP-800, NXP800, VK2019, Magnetic Resonance Imaging, Magnetic Resonance, Magnetic Resonance Imaging (MRI), Magnetic resonance imaging (procedure), Magnetic Resonance Imaging Scan, Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MR, MR Imaging, MRI, MRI Scan, MRIs, NMR Imaging, NMRI, Nuclear Magnetic Resonance Imaging, sMRI, Structural MRI, Positron Emission Tomography, Medical Imaging, Positron Emission Tomography, PET, PET Scan, Positron emission tomography (procedure), Positron Emission Tomography Scan, Positron-Emission Tomography, proton magnetic resonance spectroscopic imaging, PT, Ultrasound-Guided Biopsy, Ultrasound Biopsy, Ultrasound Guided Biopsy | Mayo Clinic | Advanced Cholangiocarcinoma, Metastatic Cholangiocarcinoma, Refractory Cholangiocarcinoma, Stage III Hilar Cholangiocarcinoma AJCC V8, Stage III Intrahepatic Cholangiocarcinoma AJCC V8, Stage IV Hilar Cholangiocarcinoma AJCC V8, Stage IV Intrahepatic Cholangiocarcinoma AJCC V8 | 05/26 | 05/26 | | |
| Active, not recruiting | 1 | 61 | US | dMAb AZD5396, dMAb AZD8076, CELLECTRA™ 2000 with Side Port needle, OpBlock 0078 Electroporation device, Hylenex, CELLECTRA™ 2000 with Side Port needle, OpBlock 0070 Electroporation device | Pablo Tebas, The Wistar Institute, AstraZeneca, Inovio Pharmaceuticals | Healthy Volunteers | 09/25 | 09/25 | | |
